Pharmacists and Pharmacy Techs: New CE Requirements. Click here for more info.

- Multimedia -

Hazardous Drugs: Is Your Practice Putting Patients & Providers at Risk? 

Activity Description

This CE activity will assess the many factors in the safe handling of hazardous drugs (HDs). Established HD safe-handling precautions, intended to minimize risk to both patients and providers, will be discussed. Participants will learn about safe-handling practices both within the pharmacy environment and throughout the healthcare facility. The entire spectrum of HD management will be discussed from formulary and purchasing, to storing, compounding, delivery, administration, and disposal.

Learning Objectives

Upon completion of this activity, pharmacists and pharmacy technicians will be able to:

  • Summarize evidence of exposure to HDs due to workplace practices

  • Outline the most recent guidelines for safe handling of HDs

  • Define the pharmacy departments level of accountability and responsibility for prevention of hazardous drug (HD) exposure in the pharmacy and throughout the entire facility

  • Identify real-life situations within and outside of the pharmacy that can result in HD exposure for hospital staff or patients

  • Outline actions that the pharmacy department and staff can take to prevent HD exposures

Faculty

Seth Eisenberg, RN, OCN
Professional Practice Coordinator Infusion Services
Seattle Cancer Care Alliance
Seattle, Washington

Firouzan Fred Massoomi, PharmD, FASHP
Pharmacy Operations Coordinator
Department of Pharmacy Services
Nebraska Methodist Hospital
Omaha, Nebraska

Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Seth Eisenberg has served as a consultant/speaker for Equashield, Hospira, and ICU Medical. Fred Massoomi has received research support from ICU Medical, and has served as a consultant/speaker for Carmel Pharma, Hospira, and ICU Medical.

Please note: The opinions expressed in this activity should not be construed as those of the CE provider, Hospira, Inc., or ICU Medical, Inc. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 01-09-2012
Expiration Date: 12-05-2014

Pharmacists and Pharmacy Technicians:
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-12-003-H05-P/T has been assigned to this knowledge-based, home-study activity (initial release date 01-09-12). This CE activity is approved for 1.0 contact hour (0.10 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of credit will be issued online upon completion of the activity evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

Funding

This activity is supported by an educational grant from ICU Medical, Inc., and Hospira, Inc.



 
To Participate

To participate in this Web-based continuing education activity:
1. Review the activity description and objectives.
2. View the activity by clicking on the link below.
3. Complete the online post-test and activity evaluation by clicking the hyperlink below (registration will be required).
View this Activity
View as Flash
Earn additional credit
(Prerequisite required)
Post-Test / Evaluation and CE Statement

To take the post-test, complete the evaluation, and to obtain your CE statement:

  • New User
    Click here to register
  • Existing User / Not Yet Enrolled in this Course
    Click here to enroll
    (previous ProCE user that has NOT yet enrolled in this specific course)
  • Existing User / Already Enrolled in the Course
    Click here
    (To resume taking the post-test OR Reprint CE Statement)
NOTE: If you attended the live CE activity titled "Hazardous Drugs: Is Your Practice Putting Patients & Providers at Risk?" that was held on December 5, 2011 during the 46th ASHP Midyear Clinical Meeting & Exhibition in New Orleans, Louisiana AND received CE credit (i.e. a pharmacist CE statement of credit with ACPE  number 221-000-11-082-L05-P/T), you are NOT allowed to also receive credit for this home-study on-demand web activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Click here for ProCE, Inc.'s Privacy Policy.